XML 23 R12.htm IDEA: XBRL DOCUMENT
v3.8.0.1

Earnings Per Share Data ("EPS") and Stock Based Compensation | 9 Months Ended
--- | ---
Sep. 30, 2017
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract] |
Earnings Per Share Data ("EPS") and Stock Based Compensation | (7) Earnings Per Share Data (“EPS”) and Stock Based Compensation Basic earnings per share are based on the weighted average number of common shares outstanding during the period. Diluted earnings per share are based on the weighted average number of common shares outstanding during the period adjusted to give effect to common stock equivalents. The following table sets forth the computation of basic and diluted earnings per share for classes A, B, C and D common stockholders for the periods indicated (in thousands, except per share data):
|  | Three months ended September 30, |  |  | Nine months ended September 30, |
|  | 2017 |  |  | 2016 |  |  | 2017 |  |  | 2016 |
Basic and Diluted: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net income attributable to UHS |  | $ | 141,245 |  |  | $ | 151,865 |  |  | $ | 532,694 |  |  | $ | 528,201 |
Less: Net income attributable to unvested restricted share grants |  |  | (81 | ) |  |  | (69 | ) |  |  | (257 | ) |  |  | (242 | )
Net income attributable to UHS – basic and diluted |  | $ | 141,164 |  |  | $ | 151,796 |  |  | $ | 532,437 |  |  | $ | 527,959 |
Weighted average number of common shares - basic |  |  | 95,246 |  |  |  | 97,118 |  |  |  | 96,026 |  |  |  | 97,278 |
Net effect of dilutive stock options and grants based on the treasury stock method |  |  | 731 |  |  |  | 1,203 |  |  |  | 771 |  |  |  | 1,257 |
Weighted average number of common shares and equivalents - diluted |  |  | 95,977 |  |  |  | 98,321 |  |  |  | 96,797 |  |  |  | 98,535 |
Earnings per basic share attributable to UHS: |  | $ | 1.48 |  |  | $ | 1.56 |  |  | $ | 5.54 |  |  | $ | 5.43 |
Earnings per diluted share attributable to UHS: |  | $ | 1.47 |  |  | $ | 1.54 |  |  | $ | 5.50 |  |  | $ | 5.36 |
The “Net effect of dilutive stock options and grants based on the treasury stock method”, for all periods presented above, excludes certain outstanding stock options applicable to each period since the effect would have been anti-dilutive. The excluded weighted-average stock options totaled 5.6 million for the nine months ended September 30, 2017. The excluded weighted-average stock options totaled 8.0 million for the three months ended September 30, 2017. The excluded weighted-average stock options totaled 2.0 million for the nine months ended September 30, 2016. There were no significant anti-dilutive stock options during the three months ended September 30, 2016. All classes of our common stock have the same dividend rights. Stock-Based Compensation: During the three-month periods ended September 30, 2017 and 2016, compensation cost of $13.1 million and $11.1 million, respectively, was recognized related to outstanding stock options. During the nine-month periods ended September 30, 2017 and 2016, compensation costs of $41.0 million and $34.7 million, respectively, was recognized related to outstanding stock options. In addition, during the three-month periods ended September 30, 2017 and 2016, compensation cost of approximately $432,000 (net of cancellations) and $390,000, respectively, was recognized related to restricted stock. During the nine-month periods ended September 30, 2017 and 2016, compensation cost of approximately $1.0 million (net of cancellations) and $1.0 million, respectively, was recognized related to restricted stock. As of September 30, 2017 there was $112.0 million of unrecognized compensation cost related to unvested options and restricted stock which is expected to be recognized over the remaining weighted average vesting period of 2.8 years. There were 2,992,725 stock options granted (net of cancellations) during the first nine months of 2017 with a weighted-average grant date fair value of $27.05 per share. There were 20,557 shares of restricted shares granted during the first nine months of 2017 with a weighted-average grant date fair value of $121.41 per share. The expense associated with share-based compensation arrangements is a non-cash charge. In the Condensed Consolidated Statements of Cash Flows, share-based compensation expense is an adjustment to reconcile net income to cash provided by operating activities and aggregated to $42.8 million and $36.4 million during the nine-month periods ended September 30, 2017 and 2016, respectively.

X
- Definition The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -URI http://asc.fasb.org/subtopic&trid=2208855 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration